Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Streubel, A. Roth, S. Stephan-Falkenau, O. Landt, C. Götz, T. Mairinger (Berlin, Germany). Evaluation of four different molecular methods for EGFR mutation analysis in exon 18, 19 and 21. Eur Respir J 2011; 38: Suppl. 55, 1958

Member's Comments

No comment yet.

Related content which might interest you: Diagnostic utility of PNA-LNA PCR clamp method for detection of EGFR exon 19 deletions and exon 21 codon L858 mutations in NSCLC samples with low tumor cells content Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 Evaluation of PNA-LNA PCR clamp method sensitivity for detection of key EGFR gene exon 19 and exon 21 mutations Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 FGFR1-4 and MET expression analysis and evaluation of reliable reference genes in Sq-NSCLC Source: International Congress 2019 – Biology of lung cancer Year: 2019 Target other gene point mutations: HER2 and rare EGFR mutations Source: ERS Research Seminar Year: 2015 Molecular profiling of Sq-NSCLC with enhanced FGFR1-4 and MET gene expression – NGS pilot study. Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020 Detection of k-ras codon 12 mutations in human lung tumour tissue by REMS-PCR Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001 Exon 22 A3650G, Intron 27 T520C and Exon 33 C5507G polymorphisms of complement receptor 1 gene are associated with idiopathic pulmonary fibrosis Source: Annual Congress 2003 - Immunology of interstitial lung diseases Year: 2003 Biological analysis of the single codon deletion in Exon 19 of EGF receptor in non-small cell lung cancer responsive to gefitinib Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Very early detection of small clones harbouring EGFR mutations in NSCLC by 2nd generation sequencing Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 Rescue of CFTR function impaired by mutations in exon 15 Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis Year: 2020 Gefitinib as first-line treatment for patients with NSCLC with activating EGFR mutationin exons 19 (Del19) or 21 (L858R) in the Czech Republic Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Novel genetic variants in alpha-1 antitripsin deficiency cases carrying S alleles and discordant genotype and serum levels Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Late Breaking Abstract: Real-time PCR versus direct sequencing in detection of EGFR T790M and L858R mutations – The sensitivity comparison Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010 Identification and characterisation of seven novel SERPINA1 null mutations Source: International Congress 2014 – Genes and environment in asthma and COPD Year: 2014 Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients Source: Eur Respir Rev 2014; 23: 390-392 Year: 2014 Validation of PNA-LNA PCR clamp assay for detection of EGFR exon 19 and 21 mutations in various types of clinical non-small cell lung cancer specimens Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 The downstream effects of the 17q12-21 asthma region. Is functional splicing of GSDMB the explanation? Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes Year: 2020 Description of new CFTR gene’s mutations in patients of Russia Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020 Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the ΔF508 mutation Source: Annual Congress 2003 - Cystic fibrosis: new genes, new controversies Year: 2003 Analysis of the human SP-A 5‘UTR exon B: Identification of regulatory regions Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010